A missing or unusually short nasal bone on prenatal ultrasound is one of the strongest individual “soft markers” for Down syndrome, but on its own it is far from a diagnosis. Studies consistently show that roughly 40 to 65 percent of fetuses with Down syndrome have an absent nasal bone in the first trimester, compared with fewer than 1 percent of unaffected fetuses. That gap makes the marker valuable for adjusting risk, yet it also means a large share of fetuses flagged this way turn out to be perfectly healthy. Understanding what the nasal bone finding actually means, and what it does not, can spare families unnecessary panic and help them make informed decisions about further testing.
Why the Nasal Bone Is Different in Down Syndrome
The flat facial profile commonly seen in people with Down syndrome is not just a surface-level feature. It traces back to differences in how the bones of the midface develop. The cranial base and nasal bridge tend to be shorter throughout growth, a pattern that begins in the womb and persists into adulthood. In fetuses with trisomy 21, nasal bone ossification, the process by which cartilage hardens into bone, is often delayed or incomplete. A pathological study of fetuses with Down syndrome found that an absent nasal bone on postmortem examination occurred in about a third of cases, and in some of those fetuses the absence appeared to reflect delayed maturation rather than a permanent structural defect.1PubMed. A histological and radiological investigation of the nasal bone in fetuses with Down syndrome
This matters for ultrasound because a bone that has not yet ossified is invisible to the ultrasound beam. The bone may technically exist as a cartilage template, but if it has not mineralized enough to reflect sound waves, it looks absent on the screen. A separate study comparing ultrasound images with actual tissue specimens found that in five of six cases initially reported as “absent nasal bone,” a retrospective review of the images could actually identify the bone. It was present but less distinct and had lower echogenicity, leading to misinterpretation.2PubMed. The nasal bone in fetuses with trisomy 21: sonographic versus pathomorphological findings So the distinction between a truly absent nasal bone and a very small, poorly ossified one is genuinely blurry on ultrasound, which has important implications for how the finding is interpreted.
How the Nasal Bone Is Measured
Getting a reliable nasal bone image requires a precise setup. The fetus needs to be in a midsagittal view, essentially a perfect side profile, and the ultrasound beam must hit the nasal bone at the right angle. If the angle is too steep or too shallow, a normal nasal bone can appear absent. In practice, sonographers aim for the nasal bone to be oriented between roughly 45 and 135 degrees relative to the ultrasound beam, and multiple measurements are typically taken.3PubMed Central. Mid-second Trimester Measurement of Nasal Bone Length in the Indian Population
The distinction between “absent” and “hypoplastic” (present but abnormally short) depends on gestational age and reference ranges. In the first trimester, around 11 to 14 weeks, the assessment is often binary: the sonographer determines whether the nasal bone is visible or not. By the second trimester, the bone is larger and can be measured in millimeters, allowing clinicians to compare its length against population norms and flag it as hypoplastic if it falls below a threshold.
First-Trimester Findings
Most of the landmark research on nasal bone screening comes from the first trimester, when the scan is often combined with a nuchal translucency measurement and blood tests. In one study of over a thousand pregnancies examined between 11 and 14 weeks, the nasal bone was absent in about two-thirds of Down syndrome cases and in only 1 percent of unaffected pregnancies.4PubMed. Measurement of nasal bone length at 11-14 weeks of pregnancy and its potential role in Down syndrome risk assessment A separate first-trimester study using a simplified assessment method found an absent nasal bone in roughly half of affected pregnancies and less than half a percent of unaffected ones.5American Journal of Obstetrics and Gynecology. First-trimester screening for trisomy-21 using a simplified method to assess the presence or absence of the fetal nasal bone
These numbers bounce around across studies, and that variation is real rather than just statistical noise. Differences in operator experience, ultrasound equipment, and the ethnic makeup of the study population all shift the results. The consistent finding, though, is that an absent nasal bone in the first trimester meaningfully increases the probability of Down syndrome, while a present nasal bone decreases it.
What the Nasal Bone Adds to Combined Screening
The nasal bone is most powerful when folded into a multi-marker screening protocol rather than used in isolation. When nasal bone assessment was combined with maternal age, nuchal translucency, and two blood markers (free beta-hCG and PAPP-A), one study modeled a detection rate of 95 percent with a false-positive rate under 3 percent.4PubMed. Measurement of nasal bone length at 11-14 weeks of pregnancy and its potential role in Down syndrome risk assessment At a stricter 1 percent false-positive cutoff, the detection rate still held above 90 percent. Those are strong numbers for a screening test, and they illustrate the value of combining markers rather than relying on any single one.
A five-year prospective study confirmed this principle in practice: adding secondary ultrasound markers including nasal bone assessment, tricuspid regurgitation, and ductus venosus flow to the standard combined biochemical-plus-nuchal-translucency protocol reduced the false-positive rate from about 4.8 percent to 3.4 percent while maintaining the same detection rate.6PubMed. First-trimester screening for chromosomal abnormalities by integrated application of nuchal translucency, nasal bone, tricuspid regurgitation and ductus venosus flow combined with maternal serum free β-hCG and PAPP-A: a 5-year prospective study That reduction matters because every false positive means a family facing weeks of anxiety and potentially an invasive procedure they did not need.
Second-Trimester Assessment
When the nasal bone is evaluated later in pregnancy, typically around 15 to 22 weeks, the approach shifts from simply checking presence or absence to measuring length and comparing it against norms. A study focused on second-trimester fetuses found that among those with Down syndrome, about 37 percent had no detectable nasal bone at all, compared with 0.5 percent of controls. For fetuses where the bone was present, a ratio of biparietal diameter to nasal bone length provided additional discrimination.7PubMed. Fetal nose bone length: a marker for Down syndrome in the second trimester
Research on how best to define “hypoplastic” in the second trimester suggests that expressing the nasal bone length as a multiple of the median (essentially, how far below average it falls relative to gestational age) outperforms other definitions for risk assessment. The further below the expected length the nasal bone measures, the higher the risk of trisomy 21.8PubMed. Likelihood ratios for fetal trisomy 21 based on nasal bone length in the second trimester: how best to define hypoplasia? Using the 5th percentile as a cutoff in one reference-range study yielded a sensitivity of about 59 percent with a 5 percent false-positive rate, which is useful but clearly less powerful than the first-trimester absent-or-present assessment combined with other markers.9PubMed. Fetal nasal bone length: reference range and clinical application in ultrasound screening for trisomy 21
A more recent study looking at mid-trimester nasal bone found that complete absence occurred in 40 percent of Down syndrome cases versus 0.03 percent of controls, giving that finding an extremely high positive likelihood ratio.10PubMed Central. Predicting down syndrome: a comparative evaluation of nasal bone length in mid-trimester pregnancy In other words, a truly absent nasal bone in the second trimester is a strong red flag, while a short-but-present bone raises risk to a lesser degree.
Ethnic Variation in Nasal Bone Length
One of the most clinically important complications is that normal nasal bone length varies significantly by ethnicity. A first-trimester study comparing non-Hispanic White, non-Hispanic Black, Hispanic, and Asian women found statistically significant differences in nasal bone length across groups, even though the fetuses were similar in overall size. Asian fetuses had the shortest average nasal bone length, and the ratio of nasal bone to crown-rump length was also smallest in this group.11PubMed. Ethnic variation of fetal nasal bone length between 11-14 weeks’ gestation
Second-trimester data tells a similar story. Nasal bone length correlates tightly with head size within each racial group, but the averages diverge between groups.12PubMed. Variation of fetal nasal bone length in second-trimester fetuses according to race and ethnicity This means a nasal bone measurement that would be considered normal for a White fetus might fall below the hypoplasia threshold if measured against a reference range built from predominantly White populations, even though it is completely normal for that fetus’s ethnic background. Using ethnicity-specific reference ranges reduces false positives and avoids unnecessary worry for families from populations with naturally shorter nasal bones.
Operator Skill Matters More Than You Might Think
The nasal bone is a tiny structure, especially in the first trimester when it may be only 2 to 3 millimeters long. That makes accurate imaging highly dependent on the sonographer’s technique and experience. A study comparing experienced and inexperienced sonographers found substantial differences in measurement variability. The researchers concluded that nasal bone assessment should only be performed by experienced, quality-controlled sonographers who have completed a minimum volume of examinations, because the consequences of misclassification ripple directly into risk calculations and the counseling that follows.13PubMed. Interobserver variability of the measurement of fetal nasal bone length between 11+0 and 13+6 gestation weeks among experienced and inexperienced sonographers
This is a practical concern for families. Not every clinic includes nasal bone assessment in its first-trimester screening protocol, partly because not all sonographers are trained and certified to perform it. If your screening did not include a nasal bone evaluation, that does not mean something was overlooked. It may simply mean your clinic follows a protocol that does not incorporate this particular marker, relying instead on other well-validated combinations.
When the Nasal Bone Finding Is Isolated
The clinical picture changes dramatically depending on whether the nasal bone finding stands alone or appears alongside other abnormalities. When an absent or hypoplastic nasal bone is the only unusual finding on an otherwise normal scan, the outlook is considerably more reassuring. In a retrospective study of 49 pregnancies with isolated nasal bone anomalies, about 18 percent of those tested showed genetic aberrations, including six cases of Down syndrome and three with other conditions. But the remaining cases without genetic findings all resulted in live births, with no neonatal deaths and only three premature deliveries.14PubMed Central. Outcomes of Pregnancies with Absent or Hypoplastic Fetal Nasal Bone: A Retrospective Analysis of Prenatal Findings and Perinatal Outcomes
Another study specifically examining euploid (chromosomally normal) fetuses with absent nasal bones found that all adverse outcomes were accompanied by additional prenatal ultrasound findings. When the nasal bone was the sole concern, newborn examinations were normal.15PubMed. Absent fetal nasal bone: what does it mean for the euploid fetus? This is an important message for families who receive this finding: an isolated nasal bone anomaly on an otherwise clean anatomy scan is a very different situation from a nasal bone anomaly combined with a thickened nuchal fold, a heart defect, or shortened long bones.
Current Guidelines and the Role of Cell-Free DNA Testing
The arrival of cell-free DNA (cfDNA) screening, sometimes called NIPT, has reshaped how nasal bone findings fit into clinical practice. A cfDNA test analyzes fragments of fetal DNA circulating in the mother’s blood and can detect trisomy 21 with high sensitivity and very low false-positive rates, often outperforming ultrasound-based screening alone. This has changed the decision tree for families facing a nasal bone finding.
Current guidance from the Society for Maternal-Fetal Medicine addresses this directly. For pregnant individuals who have not had any prior aneuploidy screening and whose ultrasound shows an isolated absent or hypoplastic nasal bone, the recommendation is counseling about the probability of trisomy 21 followed by a discussion of options: noninvasive screening through cfDNA, a quad screen if cfDNA is not available, or diagnostic testing via amniocentesis. For those who have already received a negative cfDNA screening result, the recommendation is no further aneuploidy evaluation.16American Journal of Obstetrics and Gynecology. Evaluation and management of isolated soft ultrasound markers for aneuploidy in the second trimester In other words, a reassuring cfDNA result effectively neutralizes an isolated nasal bone finding.
For some patient populations, the nasal bone retains a cost advantage. Research comparing first-trimester combined screening with nasal bone against cfDNA found a clear cost benefit to the combined ultrasound approach in women aged 35 to 39, and the inclusion of the nasal bone significantly improved that advantage. In the 40 to 44 age group the picture was less clear, depending on cfDNA pricing and whether nuchal translucency was included in the cost calculation.17American Journal of Obstetrics & Gynecology. Combined first trimester screening for Down syndrome with nasal bone (NB) is cost advantageous over NIPS in younger advanced maternal age (AMA) patients
Beyond Down Syndrome
An absent or hypoplastic nasal bone is most strongly associated with trisomy 21, but it can also appear in fetuses with other chromosomal conditions. In a study of 221 fetuses with isolated nasal bone anomalies who underwent chromosomal microarray analysis, aneuploidies were found in about 6 percent, including Down syndrome, Klinefelter syndrome, and trisomy 18.18PubMed Central. Prenatal chromosomal microarray analysis in foetuses with isolated absent or hypoplastic nasal bone A separate study using karyotyping in 84 fetuses with nasal bone hypoplasia found a higher rate of chromosomal anomalies at 25 percent, dominated by trisomy 21 but also including trisomy 18 and several rarer conditions.19PubMed Central. Chromosomal Microarray Analysis for the Prenatal Diagnosis in Fetuses with Nasal Bone Hypoplasia: A Retrospective Cohort Study The wide gap between those two studies likely reflects differences in referral patterns and how isolated the finding was, but the general point stands: clinicians investigating a nasal bone anomaly are looking for more than just Down syndrome.
The Emotional Weight of a Soft Marker Finding
Research consistently shows that receiving a “soft marker” finding on a prenatal ultrasound, even when the baby turns out to be completely healthy, takes a psychological toll. A study comparing mothers who received false-positive soft marker results with controls found significantly higher anxiety and depression scores in the soft marker group. That gap did not close after birth. At two months postpartum, the difference between groups had actually widened, and mothers in the soft marker group more frequently showed disrupted representations of their baby, including reduced involvement and ambivalent feelings.20PLOS ONE. Prenatal Ultrasound Screening: False Positive Soft Markers May Alter Maternal Representations and Mother-Infant Interaction
How the information is delivered matters. A provider’s ability to prepare patients before the ultrasound and clearly explain what an incidental finding does and does not mean is critical to reducing parental anxiety.21PubMed. Incidental Fetal Ultrasound Findings: Interpretation and Management If you are told your baby has an absent or short nasal bone, asking specific questions about context helps: Were there any other findings? What is my baseline risk? Has cfDNA screening been done? The answers to those questions shape the actual significance of the finding far more than the nasal bone result alone.
Nasal Bone Assessment in Twin Pregnancies
Screening for Down syndrome is more complicated in twins, because blood markers from two fetuses get mixed in the maternal circulation, reducing the precision of standard biochemistry. This is where the nasal bone can be especially useful, since it is an ultrasound-based marker assessed individually for each fetus. In twin pregnancies, adding nasal bone assessment to nuchal translucency and blood markers boosted the Down syndrome detection rate from about 79 percent to 89 percent at a 5 percent screen-positive rate.22American Journal of Obstetrics and Gynecology. First-trimester screening with nasal bone in twins That jump is meaningful in a population where screening accuracy is otherwise constrained.
Artificial Intelligence and the Future of Nasal Bone Imaging
Given how much the accuracy of nasal bone assessment depends on the operator’s skill, there is growing interest in using artificial intelligence to standardize the process. Researchers have developed deep-learning models designed to detect nasal bone defects and classify ultrasound images in real time, aiming to reduce the subjectivity inherent in manual assessment.23Biomedical Signal Processing and Control. FNBUI-NET: A multi-task model for fetal nasal bone ultrasound image defect detection and classification A separate system works directly from ultrasound video rather than still images, automatically identifying the correct midsagittal plane and evaluating nasal bone development in early pregnancy without requiring subjective clinical judgment at each step.24Neurocomputing. Automatic diagnosis of early pregnancy fetal nasal bone development based on complex mid-sagittal section ultrasound imaging
These tools are still in their research phase, not yet standard clinical equipment. But the potential is clear: if a computer can reliably identify the correct imaging plane and assess whether the nasal bone is present, absent, or hypoplastic, it could extend high-quality screening to clinics that currently lack operators with specialized training. It would also provide a second opinion in ambiguous cases, which are more common than most people realize given how small and angle-dependent this structure is.